Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-017717
Filing Date
2023-03-10
Accepted
2023-03-10 09:28:18
Documents
1
Period of Report
2023-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14668
  Complete submission text file 0001209191-23-017717.txt   16068
Mailing Address C/O QUEST DIAGNOSTICS 500 PLAZA DRIVE SECAUCUS NJ 07094
Business Address
GUINAN MARK (Reporting) CIK: 0001505998 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 23721848

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations